Actein
CAS: 18642-44-9
Ref. TM-T7190
1mg | 142,00 € | ||
5mg | 305,00 € | ||
10mg | 460,00 € | ||
25mg | 736,00 € | ||
50mg | 994,00 € | ||
1ml*10 (DMSO) | 408,00 € |
Información del producto
- (2S,4aR,5aR,7R,7aR,7bR,8R,12aS,12bS,14aR)-4'-hydroxy-1,1,5',7a,8,12a-hexamethyl-2-(beta-D-xylopyranosyloxy)hexadecahydro-2H-spiro[cyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]pyran-10,2'-[3,6]dioxabicyclo[3.1.0]hexan]-7-yl acetate
- (3beta,12beta,16beta,23R,24R,25S,26S))-12-(Acetyloxy)-16,23:23,26:24,25-triepoxy-26-hydroxy-9,19-cycloanostan-3-yl beta-D-xylopyranoside
- (3β,12β,16β,23R,24R,25S,26S)-12-(Acetyloxy)-16,23:23,26:24,25-triepoxy-26-hydroxy-9,19-cyclolanostan-3-yl β-<span class="text-smallcaps">D</span>-xylopyranoside
- 9,19-Cyclolanostane, β-<span class="text-smallcaps">D</span>-xylopyranoside deriv.
- Shengmating
- Spiro[5H-cyclopropa[1′,8′a]naphth[2′,1′:4,5]indeno[2,1-b]pyran-10(2H),2′-[3,6]dioxabicyclo[3.1.0]hexane], β-<span class="text-smallcaps">D</span>-xylopyranoside deriv.
- β-<span class="text-smallcaps">D</span>-Xylopyranoside, (3β,12β,16β,23R,24R,25S,26S)-12-(acetyloxy)-16,23:23,26:24,25-triepoxy-26-hydroxy-9,19-cyclolanostan-3-yl
Actein has a stimulatory effect on osteoblastic bone formation or has potential activity against osteoporosis, it also can prevent oxidative damage to osteoblasts in osteoporotic patients. Actein's ability to pathways involved in lipid disorders and carcinogenesis may make it a new agent for preventing and treating these major disorders, it has been shown to inhibit the proliferation of human breast cancer cells, by altering the activity of the ER IP3 receptor and Na,K-ATPase, inducing calcium release and modulating the NF-kB and MEK pathways.
Propiedades químicas
Consulta técnica sobre: TM-T7190 Actein
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.